Grant agreement number: (no. 2024-PRO00128)
Aim of the project: To pioneer a novel approach to early PDAC detection in Taiwan and Lithuania using proteomics and
advanced full spectrum metabolite analysis in serum, including key clinical data and/or biochemical markers, and coupled with machine learning algorithms to develop a rapid and precise diagnostic tool.
Source of funding: LithuaniaTaiwan project funds (Research Council of Lithuania)